The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma

Li,Chushi; Wu,Wei; Ding,Hongmei; Li,Qingyang; Xie,Kangkang

doi:10.3892/mmr.2018.8806

The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma

Authors:
- Chushi Li
- Wei Wu
- Hongmei Ding
- Qingyang Li
- Kangkang Xie
View Affiliations

Affiliations: Department of General Surgery, Cangnan County People's Hospital, Wenzhou, Zhejiang 325800, P.R. China
Published online on: March 28, 2018 https://doi.org/10.3892/mmr.2018.8806
Pages: 7645-7651
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aberrant activation of β‑catenin/transcription factor 7 like 2 (TCF7L2) signaling is frequently observed during the progression of hepatocellular carcinoma (HCC). However, regulation of the nuclear β‑catenin/TCF7L2 complex remains largely unknown. In the present study, immunoprecipitation and glutathione S‑transferase pull‑down assays identified transcription termination factor‑1 interacting protein 5 (TIP5) as a binding partner of TCF7L2. TIP5 activated β‑catenin/TCF7L2 signaling by enhancing the interaction between β‑catenin and TCF7L2. The results from quantitative polymerase chain reaction and western blot analysis indicated that TIP5 was upregulated in clinical HCC samples. In addition, TIP5 positively regulated the proliferation of HCC cells in the MTT assay, colony formation in the soft agar assay, migration in the Boyden chamber assay and epithelial‑mesenchymal transition of HCC cells by activating β‑catenin/TCF7L2 signaling. Therefore, the results of the present study demonstrate that TIP5 serves an oncogenic role in HCC by activating β‑catenin/TCF7L2 signaling, suggesting that TIP5 may be a promising therapeutic target for HCC.

View Figures

View References

1	Wang W, Pan Q, Fuhler GM, Smits R and Peppelenbosch MP: Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma. J Gastroenterol. 52:419–431. 2017. View Article : Google Scholar : PubMed/NCBI
2	Tao J, Zhang R, Singh S, Poddar M, Xu E, Oertel M, Chen X, Ganesh S, Abrams M and Monga SP: Targeting β-catenin in hepatocellular cancers induced by coexpression of mutant β-catenin and K-Ras in mice. Hepatology. 65:1581–1599. 2017. View Article : Google Scholar : PubMed/NCBI
3	Peng YY, He YH, Chen C, Xu T, Li L, Ni MM, Meng XM, Huang C and Li J: NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. Cancer Lett. 376:10–21. 2016. View Article : Google Scholar : PubMed/NCBI
4	Qu C, He, Lu X, Dong L, Zhu Y, Zhao Q, Jiang X, Chang P, Jiang X, Wang L, et al: Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation. J Hepatol. 64:1076–1089. 2016. View Article : Google Scholar : PubMed/NCBI
5	Polakis P: More than one way to skin a catenin. Cell. 105:563–566. 2001. View Article : Google Scholar : PubMed/NCBI
6	Suda T and Arai F: Wnt signaling in the niche. Cell. 132:729–730. 2008. View Article : Google Scholar : PubMed/NCBI
7	Nardocci G, Simonet NG, Navarro C, Langst G and Alvarez M: Differential enrichment of TTF-I and Tip5 in the T-like promoter structures of the rDNA contribute to the epigenetic response of Cyprinus carpio during environmental adaptation. Biochem Cell Biol. 94:315–321. 2016. View Article : Google Scholar : PubMed/NCBI
8	Tallant C, Valentini E, Fedorov O, Overvoorde L, Ferguson FM, Filippakopoulos P, Svergun DI, Knapp S and Ciulli A: Molecular basis of histone tail recognition by human TIP5 PHD finger and bromodomain of the chromatin remodeling complex NoRC. Structure. 23:80–92. 2015. View Article : Google Scholar : PubMed/NCBI
9	Anosova I, Melnik S, Tripsianes K, Kateb F, Grummt I and Sattler M: A novel RNA binding surface of the TAM domain of TIP5/BAZ2A mediates epigenetic regulation of rRNA genes. Nucleic Acids Res. 43:5208–5220. 2015. View Article : Google Scholar : PubMed/NCBI
10	Cong R, Das S, Ugrinova I, Kumar S, Mongelard F, Wong J and Bouvet P: Interaction of nucleolin with ribosomal RNA genes and its role in RNA polymerase I transcription. Nucleic Acids Res. 40:9441–9454. 2012. View Article : Google Scholar : PubMed/NCBI
11	Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, Bär D, Robinson MD, Baer C, Weiss M, et al: BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nat Genet. 47:22–30. 2015. View Article : Google Scholar : PubMed/NCBI
12	Fu L, Liu M, Yu X and Li X: Expressions of epithelial cell adhesion molecule, vimentin and N-cadherin in molecular subtypes of breast cancer and the correlation among them. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 41:1137–1142. 2016.(In Chinese). PubMed/NCBI
13	Furuya S, Endo K, Takahashi A, Miyazawa K and Saitoh M: Snail suppresses cellular senescence and promotes fibroblast-led cancer cell invasion. FEBS Open Bio. 7:1586–1597. 2017. View Article : Google Scholar : PubMed/NCBI
14	Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
15	Iguchi T, Yamagata M, Sonoda T, Yanagita K, Fukahori T, Tsujita E, Aishima S, Oda Y and Maehara Y: Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report. Mol Clin Oncol. 5:599–603. 2016. View Article : Google Scholar : PubMed/NCBI
16	Zhang JJ, Chen JT, Hua L, Yao KH and Wang CY: miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway. Biomed Pharmacother. 85:472–478. 2017. View Article : Google Scholar : PubMed/NCBI
17	Fan X, Ma X, Cui L, Dang S, Qu J, Zhang J, Wang X and Mao Z: CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma. Oncotarget. 7:80404–80414. 2016. View Article : Google Scholar : PubMed/NCBI
18	Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y, Adachi S, Ohwada S, Morishita Y, Shibuya H, et al: Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein. Genes Dev. 14:1741–1749. 2000.PubMed/NCBI